MarketPeel
Insider Trading Intelligence
CB

Charles S. Berkman

LGND
SVP, GEN. COUNSEL & SECRETARY · LIGAND PHARMACEUTICALS INC · CIK 0001392266
FILING MIX · LIFETIME48%/52%
BUYS
46
SELLS
49
TOTAL VALUE
$5.97M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
134,867
AVG SELL PX
$33.41
TRADE KIND
SHOWING 95 / 95
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 16 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Charles S. Berkman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+63.64%-2.06%-0.33%-1.73%-1.09%
14d11+63.64%-5.37%-0.72%-4.64%-2.81%
30d11+72.73%-9.01%-1.22%-7.78%-9.88%
60d11+90.91%-11.44%-0.12%-11.32%-15.23%
90d11(1 pending)+80.00%-20.18%+2.00%-22.18%-28.97%
180d11(3 pending)+87.50%-32.56%+8.46%-41.02%-49.55%
1y11(4 pending)+100.00%-42.44%+14.98%-57.42%-61.05%
2y11(8 pending)+100.00%-53.63%+25.89%-79.52%-70.29%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LGND · 23,825 shares · as of Nov 1, 2022
013,22626,45239,67852,90420212022SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 46 buys / 49 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
13,542406,242Apr 7, 2026Apr 7, 2026View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
7,157$1.49$10.7K399,085Apr 7, 2026Apr 7, 2026View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
13,542111,042Apr 7, 2026Apr 7, 2026View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
9,673$1.71$16.5K392,700Feb 18, 2026Feb 18, 2026View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
18,75064,584Feb 18, 2026Feb 18, 2026View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
18,750402,373Feb 18, 2026Feb 18, 2026View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
60,000124,584Feb 18, 2026Feb 18, 2026View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
600,000600,000Feb 18, 2026Feb 18, 2026View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
6,990$1.70$11.9K383,623Feb 17, 2026Feb 17, 2026View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
13,54283,334Feb 16, 2026Feb 17, 2026View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
13,542390,613Feb 16, 2026Feb 17, 2026View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
8,044$1.96$15.8K377,071Dec 8, 2025Dec 9, 2025View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
15,621385,115Dec 7, 2025Dec 9, 2025View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
15,62196,876Dec 7, 2025Dec 9, 2025View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
13,542370,418Apr 7, 2025Apr 7, 2025View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
13,542112,497Apr 7, 2025Apr 7, 2025View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
7,206$2.00$14.4K363,212Apr 7, 2025Apr 7, 2025View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
7,255$3.67$26.6K356,876Feb 19, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
56,250126,039Feb 18, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
8,215$3.68$30.2K364,131Feb 18, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
337,500337,500Feb 18, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
13,541372,346Feb 16, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
13,54169,789Feb 16, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
15,61583,330Feb 15, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
15,615358,805Feb 15, 2025Feb 19, 2025View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
25,489$3.24$82.6K343,190Jan 21, 2025Jan 22, 2025View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
45,294368,679Jan 17, 2025Jan 22, 2025View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
8,022$4.13$33.1K323,385Dec 9, 2024Dec 10, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
15,62198,945Dec 7, 2024Dec 10, 2024View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
15,621331,407Dec 7, 2024Dec 10, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
6,954$5.27$36.6K292,617Apr 8, 2024Apr 9, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
13,541114,566Apr 7, 2024Apr 9, 2024View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
13,541299,571Apr 7, 2024Apr 9, 2024View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
40,625128,107Feb 16, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
243,750243,750Feb 16, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
5,698288,064Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
15,624287,941Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
5,69887,482Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
5,575$5.54$30.9K282,366Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
15,62493,180Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
2,034$5.54$11.3K286,030Feb 15, 2024Feb 20, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
17,556108,804Jan 2, 2024Jan 3, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
7,195$6.25$45.0K272,317Jan 2, 2024Jan 3, 2024View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
17,556279,512Jan 2, 2024Jan 3, 2024View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
5,403$4.85$26.2K261,956Dec 7, 2023Dec 11, 2023View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
15,622267,359Dec 7, 2023Dec 11, 2023View →
OABI
OMNIAB, INC.
PURCHASE
Chief Legal Officer
15,622126,360Dec 7, 2023Dec 11, 2023View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
15,622126,360Dec 7, 2023Dec 12, 2023View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
243,750243,750Apr 7, 2023Apr 11, 2023View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
40,625414,564Apr 7, 2023Apr 11, 2023View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
2,166$3.80$8.2K373,939Feb 15, 2023Feb 17, 2023View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
5,404$3.80$20.5K376,105Feb 15, 2023Feb 17, 2023View →
OABI
OMNIAB, INC.
SALE
Chief Legal Officer
1,973$3.80$7.5K381,509Feb 15, 2023Feb 17, 2023View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
46,864383,482Jan 3, 2023Jan 5, 2023View →
OABI
OMNIAB, INC.
SALE
See Remarks
6,518$3.66$23.9K336,618Dec 28, 2022Dec 30, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
175,477175,477Dec 7, 2022Dec 9, 2022View →
OABI
OMNIAB, INC.
SALE
See Remarks
10,580$3.35$35.4K343,136Dec 1, 2022Dec 5, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
366,511305,412Nov 1, 2022Apr 23, 2024View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
20,1260Nov 1, 2022Nov 3, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
11,94423,825Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
17,77817,778Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
353,716353,716Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
8,3398,339Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
39,77739,777Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
62,71062,710Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
29,23729,237Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
175,477175,477Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
73,71673,716Nov 1, 2022Nov 3, 2022View →
OABI
OMNIAB, INC.
PURCHASEGRANT
Stock grant
29,77229,772Nov 1, 2022Nov 3, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,37535,769Jun 10, 2022Jun 14, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
20,12620,126May 5, 2022May 9, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
577$123.68$71.4K30,394Feb 15, 2022Feb 16, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
633$123.68$78.3K30,971Feb 15, 2022Feb 16, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
368$123.68$45.5K31,604Feb 15, 2022Feb 16, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,40130,292Jan 26, 2022Jan 28, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
1,326$113.68$150.7K31,972Jan 26, 2022Jan 28, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,83634,128Jan 26, 2022Jan 28, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
830$113.68$94.4K33,298Jan 26, 2022Jan 28, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
205$172.46$35.4K28,701Feb 15, 2021Feb 18, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
368$172.46$63.5K28,333Feb 15, 2021Feb 18, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
442$172.46$76.2K27,891Feb 15, 2021Feb 18, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
18,097$178.50$3.23M28,906Feb 4, 2021Feb 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,49147,003Feb 3, 2021Feb 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,9556,955Feb 3, 2021Feb 5, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,33542,450Jan 25, 2021Jan 27, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,40144,342Jan 25, 2021Jan 27, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
830$156.01$129.5K43,512Jan 25, 2021Jan 27, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
509$156.10$79.5K41,941Jan 25, 2021Jan 27, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
SVP, Gen. Counsel & Secretary
238$89.03$21.2K41,115Jun 30, 2020Jul 1, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
11,146$118.59$1.32M40,877Jun 4, 2020Jun 5, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
367$97.23$35.7K52,023Feb 15, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
207$97.23$20.1K52,390Feb 15, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
SVP, Gen. Counsel & Secretary
307$97.23$29.8K52,597Feb 15, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
17,22017,220Feb 13, 2020Feb 18, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,83552,904Feb 13, 2020Feb 18, 2020View →
Other insiders · LGND
Loading peer insiders…
About this filer
CIK 0001392266
ROLE
SVP, Gen. Counsel & Secretary
PRIMARY
LGND
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001392266DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback